join our newsletter
Close Window
join our newsletter
Click here to print. << Back to All Newsletters
Pelosi wants marijuana banking access included in next coronavirus relief bill, congressman says
MarijuannaMoment.com
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
With the support of House Speaker Nancy Pelosi, Representative Ed Perlmutter (D-CO) is working to include provisions to allow marijuana businesses access to banking services in an upcoming COVID-19 stimulus package.
Colorado governor asks Congress to let marijuana businesses get coronavirus aid funds
Forbes.com
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
Current SBA regulations prevent cannabis businesses and vendors from accessing emergency relief funds granted by Congress with the CARES Act. The governor of Colorado, Jared Polis, has asked Congress to include a provision in the next relief bill to ensure all state-legal cannabis businesses, direct and indirect, have access to emergency loans.
Certification for cannabis use added to telemedicine services
Arkansasonline.com
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
In Arkansas, the state government has taken an important step to make sure that potential medical cannabis patients are not excluded while social distancing. A new emergency ruling allows patients seeking cannabis for medicinal purposes to use "telemedicine" to obtain a prescription.
Epidolex removed from controlled substance list
Candidchronicle.com
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
The first FDA approved, cannabis-based pharmaceutical product finally has been removed from the Drug Enforcement Administration's controlled substance list.
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
<< Back to All Newsletters

The Science of Cannabis: April 9, 2020

At the heart of cannabis are the cannabinoids - a group of over 100 molecules that bind to the CB1 and CB2 receptors in our body. Due to years of federal prohibition, scientists know relatively little about these compounds, but the science of cannabis is quickly evolving. Private research is expanding rapidly to better understand our endocannabinoid system and why certain cannabinoid and terpene (the molecule that gives cannabis its smell and flavor) combinations have such medical and recreational impact for many consumers. Not only do we find this science fascinating, but we also believe it ultimately will prove to be very lucrative. R&D will unlock the capability to offer cannabis consumers a consistent experience at scale and will produce the patents and intellectual property that generate long-term value. The "Science of Cannabis" will be the driver behind many of the industry's long-term winners.

CONTINUE READING